Auxilius Pharma Announces Top-line Results of its First-in-Human Clinical Study into the Pharmacokinetics, Safety and Tolerability of Antianginal AUX-001
Medical Device News Magazine
by
4h ago
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium cha ..read more
Visit website
Sectra Reports Enterprise Imaging Solution Now Covers Majority of Midwest Patients Following New Contract
Medical Device News Magazine
by
4h ago
Isaac Zaworski, President of Sectra advises: "Collaborating across sites and providing efficient radiology workflows are needed to cope with the increasing imaging volumes. This new customer is the 60th healthcare provider to use Sectra in the US Midwest and I'm pleased to be continuing our work in this area. With our local experience as well as our knowledge in providing multi-site solutions for large organizations we will help them on this journey in the best way possible ..read more
Visit website
KA Imaging Reports Record Revenue Plus Strategic Hires
Medical Device News Magazine
by
4h ago
KA Imaging reported a collection of positive metrics to its stakeholders, with revenue four times larger than that of the previous year and a 38% growth in headcount in 2023. The positive trend continues to be observed in Q1 2024 ..read more
Visit website
DIAGNOSTIC IMAGING
Medical Device News Magazine
by
4h ago
..read more
Visit website
Saghmos Therapeutics Announces Notice of Allowance for Second US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator ST-62516
Medical Device News Magazine
by
7h ago
Anna Kazanchyan, MD, Founder and CEO of Saghmos Therapeutics. "We are very pleased to announce the Notice of Allowance for our second patent, which will enhance the long-term value of ST-62516. Saghmos continues to build its intellectual property estate ..read more
Visit website
RaySearch Acquires the Product DrugLog from Pharmacolog for Chemotherapy Quality Assurance
Medical Device News Magazine
by
7h ago
Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights ..read more
Visit website
B. Braun Launches Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL)
Medical Device News Magazine
by
7h ago
Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection 1,000 mL (2 units/mL), is indicated as an anticoagulant to maintain catheter patency ..read more
Visit website
Blacksmith Medicines and Zoetis Announce Research Collaboration for Novel Animal Health Antibiotics
Medical Device News Magazine
by
7h ago
This new collaboration is another example of Blacksmith's creative deal-making with top tier partners that bring expertise to the table which helps de-risk and accelerate scientific discoveries for the development of valuable products ..read more
Visit website
Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs
Medical Device News Magazine
by
7h ago
The Thermo Scientific™ Dionex™ Inuvion™ Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes. The new analytical instrument is designed to be easily reconfigurable, providing those who require determination of ionic and small polar compounds with a one stop shop for consistent, reliable ion analysis ..read more
Visit website
The University of Edinburgh Acknowledges Pelago Patent and Use of ​CETSA ® Process
Medical Device News Magazine
by
7h ago
Michael Dabrowski, CEO of Pelago Bioscience "We are grateful to the University of Edinburgh in their acknowledgement of our Patent. I encourage the drug discovery community to engage with Pelago Bioscience to explore the value that our patented CETSA technology and services can bring to enhance their drug discovery efforts ..read more
Visit website

Follow Medical Device News Magazine on FeedSpot

Continue with Google
Continue with Apple
OR